Estimating the economic and social costs of dementia in Ireland

Connolly, Sheelah; Gillespie, Paddy; O’Shea, Eamon; Cahill, Suzanne; Pierce, Maria

doi:10.1177/1471301212442453

Cited by 51 publications

(74 citation statements)

References 18 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We identified several important COI studies published since 2010 (and used these to replace older COI data). We have included new cost estimates from the USA [5], UK [6], Germany [7], Norway [8], Sweden [9], and Ireland [10]. For low- and middle-income countries (LAMIC), there is more information available regarding costs of dementia care from seven countries surveyed by the 10/66 Dementia Research Group: China, India, Cuba, Peru, Venezuela, Dominican Republic, and Mexico (PhD thesis by Liu [11]).…”

Section: Methodsmentioning

confidence: 99%

The worldwide costs of dementia 2015 and comparisons with 2010

Wimo

Guerchet

Ali

et al. 2016

Alzheimer's & Dementia

842

626

View full text Add to dashboard Cite

IntroductionIn 2010, Alzheimer's Disease International presented estimates of the global cost of illness (COI) of dementia. Since then, new studies have been conducted, and the number of people with dementia has increased. Here, we present an update of the global cost estimates.MethodsThis is a societal, prevalence-based global COI study.ResultsThe worldwide costs of dementia were estimated at United States (US) $818 billion in 2015, an increase of 35% since 2010; 86% of the costs occur in high-income countries. Costs of informal care and the direct costs of social care still contribute similar proportions of total costs, whereas the costs in the medical sector are much lower. The threshold of US $1 trillion will be crossed by 2018.DiscussionWorldwide costs of dementia are enormous and still inequitably distributed. The increase in costs arises from increases in numbers of people with dementia and in increases in per person costs.

show abstract

Section: Methodsmentioning

confidence: 99%

The worldwide costs of dementia 2015 and comparisons with 2010

Wimo

Guerchet

Ali

et al. 2016

Alzheimer's & Dementia

842

626

View full text Add to dashboard Cite

show abstract

“…This is reflected in longer length of stay (LOS) compared to those the same age without the disease, increased risk of in‐hospital complications, safety and behavioural issues requiring 1:1 care, and a higher risk of readmission . However, many of these studies that explore the economic impact of the disease extrapolate estimates based on the costs of formally diagnosed patients only . An Irish study examining the additional hospital days due to dementia estimated an associated annual cost of >€ 199 million to the Irish health system .…”

Section: Introductionmentioning

confidence: 99%

“…13,15 Patients with dementia in the acute setting are generally considered to impose higher costs on the health system. This is reflected in longer length of stay (LOS) compared to those the same age without the disease, 7,12,16,17,20,[22][23][24][25][26][27][28][29][30][31][32][33] increased risk of in-hospital complications, 21,34 safety and behavioural issues requiring 1:1 care, and a higher risk of readmission. 21 However, many of these studies that explore the economic impact of the disease extrapolate estimates based on the costs of formally diagnosed patients only.…”

Section: Introductionmentioning

confidence: 99%

Dementia in older people admitted to hospital: An analysis of length of stay and associated costs

Ahern

Cronin

Woods

et al. 2018

Int J Geriat Psychiatry

View full text Add to dashboard Cite

Objectives Patients with dementia in the acute setting are generally considered to impose higher costs on the health system compared to those without the disease largely due to longer length of stay (LOS). Many studies exploring the economic impact of the disease extrapolate estimates based on the costs of patients diagnosed using routinely collected hospital discharge data only. However, much dementia is undiagnosed, and therefore in limiting the analysis to this cohort, we believe that LOS and the associated costs of dementia may be overestimated. We examined LOS and associated costs in a cohort of patients specifically screened for dementia in the hospital setting. Methods Using primary data collected from a prospective observational study of patients aged ≥70 years, we conducted a comparative analysis of LOS and associated hospital costs for patients with and without a diagnosis of dementia. Results There was no significant difference in overall length of stay and total costs between those with (μ = 9.9 days, μ = € 8246) and without (μ = 8.25 days, μ = € 6855) dementia. Categorical data analysis of LOS and costs between the two groups provided mixed results. Conclusions The results challenge the basis for estimating the costs of dementia in the acute setting using LOS data from only those patients with a formal dementia diagnosis identified by routinely collected hospital discharge data. Accurate disease prevalence data, encompassing all stages of disease severity, are required to enable an estimation of the true costs of dementia in the acute setting based on LOS.

show abstract

“…Others stress that the discrepancies within the system are unacceptable when these data are used for assessing discharges, making comparisons with other countries and for determining funding allocation by the government (O'Callaghan et al, ). HIPE data have been used to estimate hospital dementia‐related activity in Ireland on several occasions (Connolly et al, ), and similar hospital episode statistics for dementia have been used in many countries. However, we had concerns about the effects of under‐diagnosis and under‐recording of dementia in such national hospital discharge data‐sets and took the opportunity to test the accuracy of HIPE coding in a cohort study of dementia in older people admitted to hospital.…”

Section: Introductionmentioning

confidence: 99%